Anna Thomas

Senior Director, Regulatory Affairs & Quality
Research & Development

What I do at MMV:

I provide strategic regulatory guidance and oversee global regulatory activities for MMV’s portfolio in collaboration with project teams and partners. The ultimate aim of my work is to facilitate the development and registration of new antimalarial drugs in a timely and optimal manner.

Why I work at MMV:

Having spent some time in a hospital in Africa as a volunteer, I have witnessed the devastating impact of malaria. It is therefore rewarding to use my regulatory experience towards our common mission of defeating malaria.

More about me:

I joined MMV with 15 years’ regulatory affairs experience in companies including GSK (HQ) and Eli Lilly (EU HQ) in the UK and Sanofi-aventis (HQ) in France. For the 7 years prior to joining MMV, I was Head of Regulatory Affairs at PregLem based in Geneva. Over my career, I have had the opportunity to lead regulatory developments and registration activities/strategies for EU/US/Japan/Switzerland, as well as for generics for African markets.

I hold a Pharmacist degree (Bordeaux, France) with a post graduate diploma in Regulatory development and registration (Paris, France).

Ask me about:

Regulatory development, SRA registrations, Health Authorities' meetings